These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37212967)

  • 1. Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.
    Leopoldino RWD; de Oliveira LVS; Fernandes FEM; de Lima Costa HTM; Vale LMP; Oliveira AG; Martins RR
    Int J Clin Pharm; 2023 Aug; 45(4):1007-1013. PubMed ID: 37212967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective identification and causality evaluation of suspected adverse drug reactions in neonates.
    Roberts EK; Hawcutt DB; Turner MA
    Br J Clin Pharmacol; 2021 Mar; 87(3):1541-1546. PubMed ID: 32696451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
    Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
    Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.
    Gupta SK; Kumar KD
    Int J Pharm Investig; 2017; 7(4):193-197. PubMed ID: 29692979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal profile of adverse drug reactions and associated clinical factors: a prospective observational study in a neonatal intensive care unit.
    Leopoldino RWD; Marques DP; Rocha LC; Fernandes FEM; Oliveira AG; Martins RR
    BMJ Open; 2023 Aug; 13(8):e073304. PubMed ID: 37553191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An algorithm to detect adverse drug reactions in the neonatal intensive care unit.
    Du W; Lehr VT; Lieh-Lai M; Koo W; Ward RM; Rieder MJ; Van Den Anker JN; Reeves JH; Mathew M; Lulic-Botica M; Aranda JV
    J Clin Pharmacol; 2013 Jan; 53(1):87-95. PubMed ID: 23400748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children.
    Pages N; Bounabi A; Boussaha I; Ndiaye M; Portefaix A; Simeon G; Guy C; Stagnara J; Paret N; Vial T; Eftekhari P; Floret D; Gajdos V; Langhendries JP; Bleyzac N; Alberti C; Jacqz-Aigrain E; Nguyen KA; Kassai B;
    Therapie; 2022; 77(4):397-404. PubMed ID: 34998623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
    Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
    Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse drug reactions in neonates hospitalized in neonatal intensive care units in Barranquilla, Colombia].
    De Las Salas R; Díaz-Agudelo D
    Biomedica; 2017 Apr; 37(0):33-42. PubMed ID: 28527264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.
    Pradhan P; Lavallee M; Akinola S; Escobar Gimenes FR; Berard A; Methot J; Piche ME; Gonella JM; Cloutier L; Leclerc J
    J Appl Biomed; 2023 Jun; 21(2):59-66. PubMed ID: 37376882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confidence and accuracy in identification of adverse drug reactions reported by outpatients.
    Kampichit S; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2018 Dec; 40(6):1559-1567. PubMed ID: 30367372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study.
    Um SH; Abuzgaia A; Rieder M
    Br J Clin Pharmacol; 2023 Aug; 89(8):2407-2412. PubMed ID: 36849649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions in neonates: a prospective study.
    Belén Rivas A; Arruza L; Pacheco E; Portoles A; Diz J; Vargas E
    Arch Dis Child; 2016 Apr; 101(4):371-6. PubMed ID: 26819267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three algorithms used to evaluate adverse drug reactions.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Jul; 43(7):1709-14. PubMed ID: 3752106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.